Consultation now open - proposed changes to the Options for Investment list

Kia ora,

Pharmac is now consulting publicly on a proposal to bring greater clarity and transparency to how we manage medicine funding applications on the Options for Investment (OFI) list.

We’re proposing to decline some of the lowest-ranked applications that have remained on the OFI list for more than two years, as they are unlikely to be funded under current priorities. This change aims to help people better understand our funding intentions and support more informed decision-making.

• Link to consultation

  
  

I know this will be of interest to you and your networks, and I invite you to share this information so that as many people as possible are able to provide feedback.

Consultation opened on Monday 20 October and closes at 5 pm on Monday 17 November. More information about Pharmac’s proposal, including how to provide feedback, is available at Consultation.

After we have considered the feedback received in the public consultation, the Pharmac Board will make a decision on the proposal. If approved, we expect at this stage that no changes to the OFI will be made until after a further consultation, at the earliest in mid-2026.

We will keep Pharmac’s website updated as the proposal progresses, but if you have any queries in the meantime, you are welcome to contact us at applicationfeedback@pharmac.govt.nz

Ngā mihi,

Jayne Watkins | Principal Advisor | Pharmaceuticals Directorate

Pharmac | Te Pātaka Whaioranga

___________________________________________________________________

PO Box 10-254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz